The Impact of Using Home Health Care After Thoracic Endovascular Aortic Repair
Presented During:
Thursday, April 25, 2024: 5:38PM - 7:00PM
Sheraton Times Square
Posted Room Name:
Central Park
Abstract No:
P0340
Submission Type:
Abstract Submission
Authors:
Danial Ahmad (1), Sarah Yousef (2), James Brown (1), Derek Serna-Gallegos (3), Carlos Diaz-Castrillon (4), Floyd Thoma (1), Yisi Wang (1), Michel Pompeu Sá (5), Ibrahim Sultan (3)
Institutions:
(1) UPMC, Pittsburgh, PA, (2) University of Pittsburgh, Pittsburgh, PA, (3) University of Pittsburgh Medical Center, Pittsburgh, PA, (4) University of Pittsburgh, United States, (5) PROCAPE / University of Pernambuco, Recife, Pernambuco
Submitting Author:
Danial Ahmad
-
Contact Me
UPMC
UPMC
Co-Author(s):
Sarah Yousef
-
Contact Me
University of Pittsburgh
University of Pittsburgh
James Brown
-
Contact Me
UPMC
UPMC
Derek Serna-Gallegos
-
Contact Me
University of Pittsburgh Medical Center
University of Pittsburgh Medical Center
Carlos Diaz-Castrillon
-
Contact Me
University of Pittsburgh
University of Pittsburgh
Floyd Thoma
-
Contact Me
UPMC
UPMC
Yisi Wang
-
Contact Me
UPMC
UPMC
Michel Pompeu Sá
-
Contact Me
PROCAPE / University of Pernambuco
PROCAPE / University of Pernambuco
*Ibrahim Sultan
-
Contact Me
University of Pittsburgh Medical Center
University of Pittsburgh Medical Center
Presenting Author:
Danial Ahmad
-
Contact Me
UPMC
UPMC
Abstract:
Objective: Home health care (HHC) may help reduce the burden on patients and families after interventions and potentially reduce hospital length of stay (LOS). We sought to assess outcomes of patients undergoing Thoracic Endovascular Aortic Repair (TEVAR) who were discharged with or without HHC services.
Methods: This was a retrospective analysis, using the Nationwide Readmissions Database (NRD), of TEVAR patients (2010 to 2018) who were categorized based on disposition at discharge into either the HHC cohort or the routine cohort. Propensity matching was utilized to compare the cohorts in addition to stepwise-weighted logistic regression.
Results: Of the 9170 TEVAR patients included, 27.3% (2500/9170) were discharged to HHC. Median age was 71 years (62-78) and women comprised 45.9% of the population with no differences between the groups.
Post-TEVAR rates of heart failure (HF) (4.3% vs. 2.7%, p<0.01), pneumonia (7.2% vs. 5%, p<0.01), ileus (4% vs. 2.8%, p=0.02), sepsis (1.6% vs. 0.9%), and hemorrhage (26.4% vs. 23.7%, p=0.03) were higher in the HHC cohort. The LOS for the index admission was comparable (7 days [5-12] vs. 6 days [3-12], p=0.09) as were the 30-day readmission (21.3% vs.19.6%, p=0.07) and 30-day mortality (0.17% vs. 0.25%, p=0.53) rates.
On weighted stepwise logistic regression (Table), HHC status (Odds Ratio (OR): 1.21 [95% CI: 1.11-1.32], p<0.001), female gender (0.87 [0.80-0.94], p<0.001), resident status (1.78 [1.54-2.04], p<0.001), non-elective procedure (1.62 [1.49-1.77], p<0.001), myocardial infarction (1.31 [1.18-1.44], p<0.001), arrhythmia (1.13 [1.03-1.25], p=0.01), and spinal cord ischemia (1.98 [1.26-3.10], p<0.001) were associated with 30-day readmission. Following propensity matching, HHC status did not show statistically significant association with 30-day readmission (HHC vs not: OR=1.14, 0.98-1.31, P=0.07)
Conclusion: Post-TEVAR utilization of HHC services was likely due to higher in hospital complications and trended toward association with increased odds of 30-day readmissions after propensity matching. Therefore, priority should be given to reducing TEVAR-related in-hospital complications as that may reduce HHC utilization and improve overall outcomes.
Methods: This was a retrospective analysis, using the Nationwide Readmissions Database (NRD), of TEVAR patients (2010 to 2018) who were categorized based on disposition at discharge into either the HHC cohort or the routine cohort. Propensity matching was utilized to compare the cohorts in addition to stepwise-weighted logistic regression.
Results: Of the 9170 TEVAR patients included, 27.3% (2500/9170) were discharged to HHC. Median age was 71 years (62-78) and women comprised 45.9% of the population with no differences between the groups.
Post-TEVAR rates of heart failure (HF) (4.3% vs. 2.7%, p<0.01), pneumonia (7.2% vs. 5%, p<0.01), ileus (4% vs. 2.8%, p=0.02), sepsis (1.6% vs. 0.9%), and hemorrhage (26.4% vs. 23.7%, p=0.03) were higher in the HHC cohort. The LOS for the index admission was comparable (7 days [5-12] vs. 6 days [3-12], p=0.09) as were the 30-day readmission (21.3% vs.19.6%, p=0.07) and 30-day mortality (0.17% vs. 0.25%, p=0.53) rates.
On weighted stepwise logistic regression (Table), HHC status (Odds Ratio (OR): 1.21 [95% CI: 1.11-1.32], p<0.001), female gender (0.87 [0.80-0.94], p<0.001), resident status (1.78 [1.54-2.04], p<0.001), non-elective procedure (1.62 [1.49-1.77], p<0.001), myocardial infarction (1.31 [1.18-1.44], p<0.001), arrhythmia (1.13 [1.03-1.25], p=0.01), and spinal cord ischemia (1.98 [1.26-3.10], p<0.001) were associated with 30-day readmission. Following propensity matching, HHC status did not show statistically significant association with 30-day readmission (HHC vs not: OR=1.14, 0.98-1.31, P=0.07)
Conclusion: Post-TEVAR utilization of HHC services was likely due to higher in hospital complications and trended toward association with increased odds of 30-day readmissions after propensity matching. Therefore, priority should be given to reducing TEVAR-related in-hospital complications as that may reduce HHC utilization and improve overall outcomes.
Aortic Symposium:
Descending/Thoracoabdominal Aorta
Image or Table
